Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Numinus Wellness Inc (NUMI.VN)

Numinus Wellness Inc (NUMI.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 205,349
  • Shares Outstanding, K 199,368
  • Annual Sales, $ 881 K
  • Annual Income, $ -9,601 K
  • 60-Month Beta N/A
  • Price/Sales 112.89
  • Price/Cash Flow N/A
  • Price/Book 6.31
Trade NUMI.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.14
  • Most Recent Earnings -0.03 on 02/28/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Care

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.850 +21.18%
on 05/18/21
1.070 -3.74%
on 06/10/21
+0.120 (+13.19%)
since 05/11/21
3-Month
0.740 +39.19%
on 04/21/21
1.430 -27.97%
on 03/12/21
-0.380 (-26.95%)
since 03/11/21
52-Week
0.185 +456.76%
on 08/26/20
2.450 -57.96%
on 12/15/20
+0.460 (+80.70%)
since 06/11/20

Most Recent Stories

More News
Why the North America Psychedelic Drugs Market is Expected to Grow With the Fastest CAGR for Next Several Years

/PRNewswire/ -- The illegal drugs of the 1960's are becoming highly valued drugs for various new therapeutic uses across a growing list of maladies. The door of previously prohibited drugs has been opening...

SILO : 0.2846 (-1.79%)
CMPS : 39.68 (+0.71%)
MNMD : 3.92 (+8.29%)
CLXPF : 1.5297 (+3.36%)
LKYSF : 0.8500 (+1.25%)
NUMI.VN : 1.030 (+0.98%)
OPTI.CN : 0.700 (-2.78%)
OPTHF : 0.5875 (-0.94%)
Psychedelic Drug Market Has Become a Billion Dollar Industry As Acceptable Treatments Expand

, /PRNewswire/ -- Recently, the use of psychedelics is evolving for the treatment of a variety of mental illnesses, including anxiety, depression, post-traumatic stress disorder and other related uses....

LKYSF : 0.8500 (+1.25%)
SILO : 0.2846 (-1.79%)
CMPS : 39.68 (+0.71%)
MNMD : 3.92 (+8.29%)
NUMI.VN : 1.030 (+0.98%)
CLXPF : 1.5297 (+3.36%)
Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities

, /PRNewswire/ -- Before government legislation brought the world of psychedelic drug compounds to a halt, promising research was being done in the space. As researchers and scientists took closer looks...

NUMI.VN : 1.030 (+0.98%)
JAZZ : 186.17 (+0.12%)
TRYP.CN : 0.570 (unch)
TRYPF : 0.4809 (+0.19%)
GWPH : 218.96 (-0.15%)
SEEL : 3.36 (+0.60%)
Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation

COMTEX_386506409/2669/2021-05-13T08:01:37

NUMI.VN : 1.030 (+0.98%)
Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

COMTEX_386342543/2669/2021-05-11T09:01:06

NUMI.VN : 1.030 (+0.98%)
OPTI.CN : 0.700 (-2.78%)
OPTHF : 0.5875 (-0.94%)
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, and Numinus...

NUMI.VN : 1.030 (+0.98%)
OPTI.CN : 0.700 (-2.78%)
OPTHF : 0.5875 (-0.94%)
Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD

COMTEX_386277973/2669/2021-05-10T11:26:22

NUMI.VN : 1.030 (+0.98%)
Top Mushroom Stocks Sprouting on the Health and Witness Trend

Now more than ever, millions of people are focused on their health and wellness. It’s why many ...

HAVLF : 0.5583 (+0.41%)
HALO : 42.79 (+2.56%)
HCANF : 0.0540 (-1.82%)
NUMI.VN : 1.030 (+0.98%)
LKYSF : 0.8500 (+1.25%)
CMPS : 39.68 (+0.71%)
PSYCF : 0.2262 (-8.75%)
HAVN.CN : 0.680 (unch)
PSYC.CN : 0.270 (-10.00%)
Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol

Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased...

NUMI.VN : 1.030 (+0.98%)
OPTI.CN : 0.700 (-2.78%)
OPTHF : 0.5875 (-0.94%)
Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC

Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC

NUMI.VN : 1.030 (+0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 1.107
2nd Resistance Point 1.083
1st Resistance Point 1.057
Last Price 1.030
1st Support Level 1.007
2nd Support Level 0.983
3rd Support Level 0.957

See More

52-Week High 2.450
Fibonacci 61.8% 1.585
Fibonacci 50% 1.317
Fibonacci 38.2% 1.050
Last Price 1.030
52-Week Low 0.185

See More

Business Summary

Numinus Wellness Inc is engaged in the business of providing integrated health services. The company's operating segments include Salvation Botanicals and Numinus Health. It generates maximum revenue from the Salvation Botanicals segment. Salvation Botanicals segment provides analytical services which...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar